Low Dose Naltrexone in the Treatment of Crohn’s Disease: A Case Series (Abstract)

Tu1365 Low Dose Naltrexone in the Treatment of Crohn’s Disease: A Case Series Gastroenterology April 2015 https://www.gastrojournal.org/article/S0016-5085(15)32952-8/abstract INTRODUCTION:: Crohn’s disease, a form of inflammatory bowel disease (IBD), is a chronic, relapsing condition that may evade remission despite new therapies. Many patients after years of disease may become resistant to previously effective treatments and thus different […]

Therapy with the Opioid Antagonist Naltrexone Promotes Mucosal Healing in Active Crohn’s Disease… (Abstract)

Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn’s disease: a randomized placebo-controlled trial Dig Dis Sci July 2011 https://pubmed.ncbi.nlm.nih.gov/21380937/  Background: Endogenous opioid peptides have been shown to play a role in the development and/or perpetuation of inflammation. We hypothesize that the endogenous opioid system is involved in inflammatory bowel disease, and […]

Low-dose naltrexone for treatment of duodenal Crohn’s disease in a pediatric patient (Abstract)

Low-dose naltrexone for treatment of duodenal Crohn’s disease in a pediatric patient Inflamm Bowel Dis September 2010 https://academic.oup.com/ibdjournal/article/16/9/1457/4628412 Naltrexone is an opioid receptor antagonist used as an opiate antidote. It acts as a competitive antagonist at several opioid receptor sites, showing the highest affinity for mu receptors. Studies have shown that opioids have immunomodulatory activity, […]

Low-dose naltrexone therapy improves active Crohn’s disease (Abstract)

Low-dose naltrexone therapy improves active Crohn’s disease Am J Gastroenterol April 2007 https://pubmed.ncbi.nlm.nih.gov/17222320/ Objectives: Endogenous opioids and opioid antagonists have been shown to play a role in healing and repair of tissues. In an open-labeled pilot prospective trial, the safety and efficacy of low-dose naltrexone (LDN), an opioid antagonist, were tested in patients with active […]

Psychoneuroimmunological approach to gastrointestinal related pain IAbstract)

Psychoneuroimmunological approach to gastrointestinal related pain Scand J Pain October 2017 https://pubmed.ncbi.nlm.nih.gov/29122501/ Background and purpose (aims): Psychoneuroimmunology is both a theoretical and practical field of medicine in which human biology and psychology are considered an interconnected unity. Through such a framework it is possible to elucidate complex syndromes in gastrointestinal related pain, particularly chronic non-malignant. […]

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients (Abstract)

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients J Transl Med 09 March 2018 https://pubmed.ncbi.nlm.nih.gov/29523156/ Background: Around 30% of patients with inflammatory bowel disease (IBD) are refractory to current IBD drugs or relapse over time. Novel treatments are called for, and low dose Naltrexone (LDN) may provide a safe, easily accessible […]

Low dose naltrexone for induction of remission in Crohn’s disease (Abstract)

Low dose naltrexone for induction of remission in Crohn’s disease Cochrane Database Syst Rev 01 April 2018 https://pubmed.ncbi.nlm.nih.gov/29607497/ Background: Crohn’s disease is a transmural, relapsing inflammatory condition afflicting the digestive tract. Opioid signalling, long known to affect secretion and motility in the gut, has been implicated in the inflammatory cascade of Crohn’s disease. Low dose […]

Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders (Abstract)

Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders Int J Pharm Compd Mar-Apr 2010 https://mail.google.com/mail/u/0?ui=2&ik=b5d7923c33&attid=0.2&permmsgid=msg-f:1668161843235939361&th=1726805badf06421&view=att&disp=safe Use of low dose naltrexone has been advocated for a variety of medical problems. Only a few articles published in peer review journals have documented side effects of low dose naltrexone. The purpose of this study was to […]

The Benefits of Low Dose Naltrexone (Abstract)

The Benefits of Low Dose Naltrexone JewishLink 21 May 2020 https://jewishlink.news/monthly-sections/health-link-new/37942-the-benefits-of-low-dose-naltrexone Low dose naltrexone (LDN) fights the effects of a malfunctioning immune system and chronic inflammation, especially those with nervous system inflammation. There is a growing foundation of medical literature that supports the benefit of LDN in more than 30 disease states. A very good […]

Low-dose naltreoxone for the treatment of irritable bowel syndrome: a pilot study (Abstract)

Low-dose naltreoxone for the treatment of irritable bowel syndrome: a pilot study Dig Dis Sci November 2006 https://pubmed.ncbi.nlm.nih.gov/17080248/ Preclinical studies have shown that a very low dose of naltreoxone hydrochloride (NTX), an opiate antagonist, can block excitatory opioid receptors without affecting inhibitory opioid receptors, resulting in analgesic potency without side effects. The present study assessed […]